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Some of us may remember conferences with sessions 
entitled ‘Why 3D?’ Such sessions are a thing of the past 
now because there is an accumulating body of evidence – 
joined by the recent article from Leslie and colleagues 
[1]  – demonstrating the importance and utility of 3D 
culture systems to discover and model biological process 
with in vivo relevance. For example, when normal and 
malignant human breast cells are placed in 3D cultures of 
laminin-rich gels, the former cells form growth-arrested, 
lumen-containing acini and the latter cells form dis-
organized structures [2]. Inhibitors of epidermal growth 
factor receptor and β1-integrin can ‘revert’ the malignant 
phenotype, and each inhibitor downmodulates its own 
target as well as the other targets only in 3D but not in 
cells grown as monolayer cultures – suggesting that 
signaling pathways reciprocally regulate each other to 
maintain the transformed state [3]. ErbB2/HER2-induced 
transformation of 3D structures, but not cell prolifera-
tion, requires disruption of the Par6 cell polarity pathway 
[4]. Th  is requirement for deregu  lation of cell polarity 
pathways is also observed during ErbB2-induced mam-
mary tumori  genesis in mouse models of human breast 
cancer [5]. Cells in a 3D matrix can thus provide novel 
and un  expected insights into cancer biology.
Leslie and colleagues demonstrate an unexpected role 
for the 3D context in regulating the ability of H-RasV12 
to induce IL-6 and activate STAT3 [1]. Consistent with 
previous reports on the role played by STAT3 [6,7], the 
authors ﬁ  rst demonstrate that downregulation of STAT3 
inhibits the ability of H-RasV12 to transform MCF-10A 
cells. While there was no increase in tyrosine phos-
phorylation of STAT3 when H-RasV12-transformed 
MCF-10A cells were grown as monolayer cultures, the 
authors surpris  ingly observed a signiﬁ   cant increase in 
phospho-STAT3 and IL-6, a potent activator of STAT3 
phosphorylation in tumors derived from H-RasV12-
transformed MCF-10A cells. In addition, spontaneous 
mouse mammary tumors induced by expression of K-Ras 
under the control of the mouse mammary tumor virus 
promoter also show an increase in phospho-Stat3 and 
IL-6.
Th  ese observations suggest that STAT3 phosphoryla-
tion may be speciﬁ  c to the context in which cells are 
grown. Th  e authors conﬁ  rm this possibility by demon-
strating that Ras-transformed MCF-10A cells induce 
expression of IL-6 and activate STAT3 phosphorylation 
when cultured on a bed of Matrigel or Laminin matrix 
but not when grown as monolayer cultures [1]. To rule 
out the possibility that cells in monolayer cultures lost 
their ability to respond to IL-6, the authors treated the 
Ras-transformed cells with exogenous IL-6 and 
demonstrate that the cells possess the ability to induce 
STAT3 phosphorylation in response to IL-6. Th   ey go on 
to demonstrate that the culture context is critical not 
only for the activation but also for maintenance of the 
Ras–IL-6–STAT3 signaling network. Culturing tumor 
cells from xenograft or Ras-driven primary mouse 
mammary tumors for a few passages as monolayers 
results in the cells losing their ability to both express IL-6 
and induce phosphorylation of STAT3.
Th  ese results, however, diﬀ  er from a previous report 
where H-RasV12-transformed SV-40 T/t-Ags and hTERT 
immortalized human mammary epithelial cells express 
Abstract
The behavior of a cell is signifi  cantly infl  uenced by 
its context. Epithelial cells derived from glandular 
organs such as the breast recreate their glandular 
organization when grown under 3D culture conditions. 
While traditional monolayer cultures are powerful 
tools to understand how cells proliferate, grow and 
respond to stress, they do not recreate the 3D property 
observed in vivo. Multiple studies demonstrate that 3D 
organization can reveal novel and unexpected insights 
into the mechanisms by which normal and tumor-
derived epithelial cells function. In the present article 
we comment on a study that reports identifi  cation of 
a RasV12-induced IL-6 signaling network in mammary 
epithelial cells in 3D cultures.
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© 2011 BioMed Central LtdIL-6 even in monolayer cultures [8]. It is possible that an 
explanation can be oﬀ  ered by considering the diﬀ  eren-
tiation status of MCF-10A and hTERT human mammary 
epithelial cells. Unlike hTERT immortalized human 
mammary epithelial cells, which consist of a mixture of 
cells with epithelial and mesenchymal morphology, the 
MCF-10A cells have a strict epithelial, cobblestone 
morphology. Epithelial cells and mesenchymal cells may 
respond diﬀ  erently to H-RasV12-induced activa  tion of 
the IL-6–STAT3 path  way. Mesenchymal cells may 
activate autocrine production of IL-6 in response to 
expression of oncogenic Ras, whereas epithelial cells do 
not. Interestingly, the authors show that activation of 
STAT3 leads to repression of E-cadherin expression and, 
conversely, inhibition of IL-6 or JAK restored expression 
of E-cadherin. It is possible that activation of the IL-6–
STAT3 signaling pathway induces a loss of epithelial 
characteristics and pushes cells towards a mesenchymal 
state.
Consistent with this possibility, previous studies have 
shown that stimulation of breast cancer cell lines with 
exogenous IL-6 induces STAT3 activation and down-
regulation of E-cadherin to induce epithelial to mesen-
chymal transition [9]. Th  is process can set up a feed-
forward loop where the presence of IL-6 in tumors, 
produced either by the cancer cells themselves or by 
immune cells in the tumor microenvironment, can induce 
tumor epithelial cells to transition to a diﬀ  eren  tiation state 
that confers properties such as migration, invasion and 
resistance to therapy. Not entirely clear, however, is 
whether the presence of the mesenchymal state is 
suﬃ   cient to couple Ras signaling to activation of the IL-6/
STAT3 pathway because K-RasV12-induced trans-
formation of NIH3T3 cells does not induce phos  phory-
lation of STAT3 [10]. Leslie and colleagues show that 
culturing epithelial cells in a 3D matrix or in vivo activates 
the right nodes in the intracellular signaling network that 
can now induce the Ras–IL-6–STAT3 net  work. How is 
this achieved? A lot remains to be under  stood.
Given that an increase in circulating IL-6 levels is 
strongly associated with poor clinical prognosis in 
patients with breast cancer [11], and that autocrine 
production of IL-6 promotes multidrug resistance in 
breast cancer cells [11], the mechanisms by which expres-
sion of IL-6 is regulated in breast cancer is of signiﬁ  cant 
clinical importance. Th  e study by Leslie and colleagues 
further highlights the importance of culture context 
when investigating signaling networks in breast epithelial 
cells and emphasizes the importance of using in vivo and 
3D culture models to verify and validate the observations 
made in monolayer cultures.
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